用pMHC结合抗体向细胞内抗原:一种菌体显示方法
Zhiyuan Yang1, Zhihao Wu2, Brian H Santich3
1Eureka Therapeutics, Emeryville, CA, USA.
Methods in molecular biology (Clifton, N.J.)
|September 7, 2023
概括
产生针对MHC (pMHC) 复合体的抗体对于癌症治疗至关重要. 体显示提供了一种快速的方法来产生高亲和度,特异性抗体,克服传统技术的局限性.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 抗体结合MHC (pMHC) 复合体模仿T细胞受体 (TCRs).
- 这些抗体对于了解T细胞生物学和开发癌症治疗药物非常有价值.
- 传统的抗体生成方法面临着由于表位体大小和过程效率低下的挑战.
研究的目的:
- 描述菌体显示方法,用于产生针对pMHC复合体的抗体.
- 突出一个细胞选策略,用于快速产生抗体.
- 为了在产生的抗体中实现高特异性和亲和力.
主要方法:
- 利用菌体显示技术进行抗体生成.
- 实施针对性抗体选择的细胞选策略.
- 克服混合瘤和B细胞分类技术的局限性.
主要成果:
- 证明了针对pMHC复合物的抗体的快速生成.
- 在产生的抗体中实现了高特异性和亲和力.
- 为传统的抗体生成方法提供了可行的替代方案.
结论:
- 菌体显示是一种有效的策略,用于产生pMHC特异性抗体.
- 这种方法加速了潜在的癌症治疗方法的开发.
- 描述的方法比传统的抗体生成技术具有优势.
相关概念视频
01:31Hybridoma Technology
14.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.9K
01:26Antigens Involved in Adaptive Immunity
536
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
536